Abbvie Inc (NYSE:ABBV)

89.08
Delayed Data
As of Sep 21
 -0.01 / -0.01%
Today’s Change
62.55
Today|||52-Week Range
101.28
+0.61%
Year-to-Date
AbbVie (ABBV) Stock Moves -1.13%: What You Should Know
Sep 21 / Zacks.com - Paid Partner Content
2 Biotech Stocks with Jaw-Dropping Growth Potential
Sep 13 / MotleyFool.com - Paid Partner Content
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income - September 21, 2020
Sep 21 / Zacks.com - Paid Partner Content
Dividend Income Update: August 2020
Sep 13 / Seeking Alpha - Paid Partner Content
Novartis Announces Data on Tafinlar, Mekinist & Piqray at ESMO
Sep 21 / Zacks.com - Paid Partner Content
Dividend Aristocrat AbbVie Declares Its Latest Payout; Yield Is 5.3%
Sep 11 / MotleyFool.com - Paid Partner Content
Build The Ultimate, 6.6%-Yielding, Sleep-Well-At-Night Retirement Portfolio With These 17 Blue-Chips
Sep 21 / Seeking Alpha - Paid Partner Content
AbbVie declares $1.18 dividend
Sep 11 / Seeking Alpha - Paid Partner Content
The Retiree's Dividend Portfolio - Jane's August Update: Preferred Exchange
Sep 21 / Seeking Alpha - Paid Partner Content
Pharma Stock Roundup: AZN & PFE's Coronavirus Vaccine Updates & FDA Approvals
Sep 11 / Zacks.com - Paid Partner Content
50 Billionaire Holdings, 27 Pay Dividends, 2 To Buy In September
Sep 18 / Seeking Alpha - Paid Partner Content
Allergan's ex-CEO Brent Saunders launching blank-check company
Sep 11 / Seeking Alpha - Paid Partner Content
Why Pfizer Is Seriously Mispriced
Sep 18 / GuruFocus News - Paid Partner Content
2 Top Dividend Stocks to Buy in a Stock Market Crash
Sep 11 / MotleyFool.com - Paid Partner Content
2 Great Pharma Stocks to Buy in the Next Market Crash
Sep 18 / MotleyFool.com - Paid Partner Content
Is AbbVie Stock a Buy?
Sep 11 / MotleyFool.com - Paid Partner Content
3 Cheap Stocks You Can Buy and Hold for Decades
Sep 18 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Alphabet, UnitedHealth, AbbVie, Adobe Systems and Anheuser-Busch
Sep 10 / Zacks.com - Paid Partner Content
AbbVie - Still A 20% Undervalued, High-Yielding Buy
Sep 18 / Seeking Alpha - Paid Partner Content
Zacks Market Edge Highlights: MRK, ABBV, PXD, VBR and VIOO
Sep 10 / Zacks.com - Paid Partner Content
Interest Rates And Their Impact On Stock Values
Sep 17 / Seeking Alpha - Paid Partner Content
When Tech Stocks Fail You, Choose These 5 Undervalued, Low-Risk Dividend Aristocrats
Sep 10 / Seeking Alpha - Paid Partner Content
AbbVie: High Yield Dividend Anxiety
Sep 17 / Seeking Alpha - Paid Partner Content
20 More Stocks I Hope To Buy During The Next Market Sell-Off (High Yield Edition)
Sep 10 / Seeking Alpha - Paid Partner Content
Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio
Sep 17 / Zacks.com - Paid Partner Content
Top Stock Reports for Alphabet, UnitedHealth & AbbVie
Sep 09 / Zacks.com - Paid Partner Content
RH, Edgewell Personal Care, Home Depot, AbbVie and QUALCOMM highlighted as Zacks Bull and Bear of the Day
Sep 17 / Zacks.com - Paid Partner Content
Generation X Investors: Deja Vu?
Sep 09 / Zacks.com - Paid Partner Content
AbbVie: The Best Dividend Growth Challenger In The Margin Of Safety
Sep 17 / Seeking Alpha - Paid Partner Content
Simple Secrets Anyone Can Use to Reach Early Retirement - September 09, 2020
Sep 09 / Zacks.com - Paid Partner Content
AbbVie Inc. (ABBV) CEO Rick Gonzalez Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)
Sep 16 / Seeking Alpha - Paid Partner Content
September 2020 Stocks - Financials, Real Estate, Industrials, IT And Pharma
Sep 09 / Seeking Alpha - Paid Partner Content
Income Investors: Boost Your Income Using Call Options
Sep 16 / Seeking Alpha - Paid Partner Content
A 91 Kiplinger 'Most Reliable Dividend Stocks On Earth' September Update
Sep 09 / Seeking Alpha - Paid Partner Content
Tracking Jeremy Grantham's GMO Capital Portfolio - Q2 2020 Update
Sep 16 / Seeking Alpha - Paid Partner Content
Novartis (NVS) Releases Positive Data on Enerzair Breezhaler
Sep 08 / Zacks.com - Paid Partner Content
3 Stocks to Buy Now for Growth & Dividends to Counter Low Bond Yields
Sep 15 / Zacks.com - Paid Partner Content
AbbVie I-Mab Cancer Deal, And Other News: The Good, Bad And Ugly Of Biopharma
Sep 08 / Seeking Alpha - Paid Partner Content
Merger Monday Confirms An Active Stock Market - Buy Under-Appreciated Biotech
Sep 15 / Seeking Alpha - Paid Partner Content
Nicholas Ward's Dividend Growth Portfolio: August 2020 Review
Sep 07 / Seeking Alpha - Paid Partner Content
AbbVie: The Time Is Now
Sep 15 / Seeking Alpha - Paid Partner Content
33 Dividend Stocks Fit For COVID-19 Times: A September Update
Sep 07 / Seeking Alpha - Paid Partner Content
Dividend Aristocrats See 6 Star September Selections
Sep 15 / Seeking Alpha - Paid Partner Content
Calm Down: This Time Won't Be Different
Sep 06 / Seeking Alpha - Paid Partner Content
AbbVie (ABBV) Gains But Lags Market: What You Should Know
Sep 14 / Zacks.com - Paid Partner Content
Week In Review: I-Mab Partners CD47 With AbbVie In $2 Billion Deal
Sep 06 / Seeking Alpha - Paid Partner Content
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - September 14, 2020
Sep 14 / Zacks.com - Paid Partner Content
Graybug Vision readies IPO
Sep 05 / Seeking Alpha - Paid Partner Content
The Extreme Risks of Trading Your Own Retirement Assets - September 14, 2020
Sep 14 / Zacks.com - Paid Partner Content
August 2020 Dividend Portfolio Update
Sep 05 / Seeking Alpha - Paid Partner Content